A phenotypic screening platform for identifying chemical modulators of astrocyte reactivity

Benjamin L. Clayton, Institute for Glial Sciences, Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA. benjamin.clayton@case.edu.
James D. Kristell, Institute for Glial Sciences, Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Kevin C. Allan, Institute for Glial Sciences, Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Erin F. Cohn, Institute for Glial Sciences, Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Molly Karl, Department of Anatomy and Cell Biology, George Washington University School of Medicine, Washington, DC, USA.
Andrew D. Jerome, Department of Neurology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Eric Garrison, Department of Anatomy and Cell Biology, George Washington University School of Medicine, Washington, DC, USA.
Yuka Maeno-Hikichi, Institute for Glial Sciences, Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Annalise M. Sturno, Institute for Glial Sciences, Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Alexis Kerr, Institute for Glial Sciences, Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
H Elizabeth Shick, Institute for Glial Sciences, Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Jesse A. Sepeda, Department of Neurology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Eric C. Freundt, Department of Biology, The University of Tampa, Tampa, FL, USA.
Andrew R. Sas, Department of Neurology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Benjamin M. Segal, Department of Neurology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Robert H. Miller, Department of Anatomy and Cell Biology, George Washington University School of Medicine, Washington, DC, USA.
Paul J. Tesar, Institute for Glial Sciences, Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA. paul.tesar@case.edu.

Document Type

Journal Article

Publication Date

4-1-2024

Journal

Nature neuroscience

Volume

27

Issue

4

DOI

10.1038/s41593-024-01580-z

Abstract

Disease, injury and aging induce pathological reactive astrocyte states that contribute to neurodegeneration. Modulating reactive astrocytes therefore represent an attractive therapeutic strategy. Here we describe the development of an astrocyte phenotypic screening platform for identifying chemical modulators of astrocyte reactivity. Leveraging this platform for chemical screening, we identify histone deacetylase 3 (HDAC3) inhibitors as effective suppressors of pathological astrocyte reactivity. We demonstrate that HDAC3 inhibition reduces molecular and functional characteristics of reactive astrocytes in vitro. Transcriptional and chromatin mapping studies show that HDAC3 inhibition disarms pathological astrocyte gene expression and function while promoting the expression of genes associated with beneficial astrocytes. Administration of RGFP966, a small molecule HDAC3 inhibitor, blocks reactive astrocyte formation and promotes neuroprotection in vivo in mice. Collectively, these results establish a platform for discovering modulators of reactive astrocyte states, inform the mechanisms that control astrocyte reactivity and demonstrate the therapeutic benefits of modulating astrocyte reactivity for neurodegenerative diseases.

Department

Anatomy and Regenerative Biology

Link to Full Text

Share

COinS